Alternative core development around the tetracyclic indole class of HCV NS5A inhibitors.
暂无分享,去创建一个
James I. Fells | E. Asante-Appiah | C. Coburn | M. Dwyer | A. Nomeir | R. Soll | P. Meinke | S. Agrawal | E. Xia | Anilkumar G. Nair | Ling Tong | Wensheng Yu | Lei Chen | J. Kozlowski | Rong Liu | P. Ingravallo | R. Kong | Y. Zhai | Bin Hu | B. Zhong | O. Selyutin | S. Rosenblum | Yueheng Jiang